SCHEMBL8375779

SCHEMBL8375779

[CH2]CC(I)c1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.50
CYP2C9 P11712 2/20 0.50
CYP1A2 P05177 2/20 0.50
ALDH1A1 P00352 2/20 0.50
SLC6A4 P31645 1/20 0.40
ACP3 P15309 3/20 0.39
AOC3 Q16853 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2A6 P11509 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ADRA2A P08913 3/20 0.37
ADRA2B P18089 3/20 0.37
ADRA2C P18825 3/20 0.37
ADRA1D P25100 2/20 0.37
ADRA1A P35348 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15427996 0.82 CYP2C19 (0.52) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL11742196 0.80 CYP2C19 (0.50) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL20691826 0.80 CYP1A2 (0.50) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL3246866 0.79 ALDH1A1 (0.54) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL28140563 0.78 CYP2C9 (0.52) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL28256864 0.77 ALDH1A1 (0.56) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL7774238 0.76 ALDH1A1 (0.60) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL264495 0.76 ALDH1A1 (0.50) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL7453633 0.76 ALDH1A1 (0.50) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4
SCHEMBL5010133 0.74 SLC6A4 (0.58) CYP2C19CYP2C9CYP1A2ALDH1A1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
CN-1216986-A Isoxazole derivatives SANKYO CO (JP) 1999-05-19 CN disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed